<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37213040</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>An SPG7 mutation as a novel cause of monogenic progressive muscular atrophy.</ArticleTitle><Pagination><StartPage>3303</StartPage><EndPage>3305</EndPage><MedlinePgn>3303-3305</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-023-06867-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Progressive muscular atrophy (PMA) is a rare adult-onset neurological disease that is characterized by isolated lower motor neuron degeneration. While it is still disputable whether PMA is a subtype of amyotrophic lateral sclerosis (ALS) or an isolated disorder, it is well-established as a clinically defined entity. About 5% of PMA cases are monogenic, and the implicated genes largely overlap with those causing monogenic ALS.</AbstractText><AbstractText Label="CASE DESCRIPTION" NlmCategory="METHODS">Here we describe a 68-year-old female patient with progressive and asymmetric upper-limb weakness throughout an 18-month period, with muscle atrophy, dysphagia and slurring of speech. The lower limbs were unaffected, and there was no sign of upper motor neuron dysfunction. Comprehensive genetic testing for single nucleotide and copy-number variants revealed a pathogenic monoallelic variant c.1529C&gt;T, p.(Ala510Val) in the SPG7 gene.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Pathogenic biallelic SPG7 variants have been originally associated with hereditary spastic paraplegia, but other phenotypes are nowadays known to be linked to these variants, such as ALS. However, there is no report of this (or any) other SPG7 variant in association with PMA, whether it progressed to ALS or not. In conclusion, we present the first known case of PMA associated with a monoallelic SPG7 mutation.</AbstractText><CopyrightInformation>&#xa9; 2023. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>&#xc2;ngela</ForeName><Initials>&#xc2;</Initials><AffiliationInfo><Affiliation>Centro Materno-Infantil do Norte, Centro Hospital Universit&#xe1;rio de Santo Ant&#xf3;nio, Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital de Braga, Braga, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tkachenko</LastName><ForeName>Nataliya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centro de Gen&#xe9;tica M&#xe9;dica Doutor Jacinto Magalh&#xe3;es (CGM), Centro Hospitalar Universit&#xe1;rio de Santo Ant&#xf3;nio, Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortuna</LastName><ForeName>Ana Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Centro de Gen&#xe9;tica M&#xe9;dica Doutor Jacinto Magalh&#xe3;es (CGM), Centro Hospitalar Universit&#xe1;rio de Santo Ant&#xf3;nio, Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Genetyca-ICM, Atrys, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>M&#xe1;rcio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Corino de Andrade Unit, Centro Hospitalar Universit&#xe1;rio de Santo Ant&#xf3;nio, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Silva</LastName><ForeName>Jorge Diogo</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Centro de Gen&#xe9;tica M&#xe9;dica Doutor Jacinto Magalh&#xe3;es (CGM), Centro Hospitalar Universit&#xe1;rio de Santo Ant&#xf3;nio, Porto, Portugal. jorge.diogo.silva@chporto.min-saude.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal. jorge.diogo.silva@chporto.min-saude.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. jorge.diogo.silva@chporto.min-saude.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICVS/3B's-PT Government Associate Laboratory, Braga/Guimar&#xe3;es, Portugal. jorge.diogo.silva@chporto.min-saude.pt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="C112889">SPG7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D000074183">ATPases Associated with Diverse Cellular Activities</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="D008666">Metalloendopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015419" MajorTopicYN="Y">Spastic Paraplegia, Hereditary</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074183" MajorTopicYN="N">ATPases Associated with Diverse Cellular Activities</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008666" MajorTopicYN="N">Metalloendopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Motor neuron degeneration</Keyword><Keyword MajorTopicYN="N">Neurological disease</Keyword><Keyword MajorTopicYN="N">Progressive muscular atrophy</Keyword><Keyword MajorTopicYN="N">SPG7</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37213040</ArticleId><ArticleId IdType="doi">10.1007/s10072-023-06867-w</ArticleId><ArticleId IdType="pii">10.1007/s10072-023-06867-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patten SA, Armstrong GAB, Lissouba A et al (2014) Fishing for causes and cures of motor neuron disorders. Dis Model Mech 7:799&#x2013;809. https://doi.org/10.1242/dmm.015719</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.015719</ArticleId><ArticleId IdType="pubmed">24973750</ArticleId><ArticleId IdType="pmc">4073270</ArticleId></ArticleIdList></Reference><Reference><Citation>Liewluck T, Saperstein DS (2015) Progressive muscular atrophy. Neurol Clin 33:761&#x2013;773. https://doi.org/10.1016/j.ncl.2015.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.005</ArticleId><ArticleId IdType="pubmed">26515620</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddique N, Siddique T (1993) In: Adam MP, Everman DB, Mirzaa GM et al (eds) Amyotrophic lateral sclerosis overview, Seattle (WA)</Citation></Reference><Reference><Citation>Casari G, De Fusco M, Ciarmatori S et al (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973&#x2013;983. https://doi.org/10.1016/s0092-8674(00)81203-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)81203-9</ArticleId><ArticleId IdType="pubmed">9635427</ArticleId></ArticleIdList></Reference><Reference><Citation>Casari G, Marconi R (1993) Spastic paraplegia 7. In: Adam MP, Everman DB, Mirzaa GM et al (eds) Gene Reviews, Seattle (WA)</Citation></Reference><Reference><Citation>Osmanovic A, Widjaja M, F&#xf6;rster A et al (2020) SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia. J Neurol 267:2732&#x2013;2743. https://doi.org/10.1007/s00415-020-09861-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09861-w</ArticleId><ArticleId IdType="pubmed">32447552</ArticleId><ArticleId IdType="pmc">7419373</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Ferrero E, Coto E, Beetz C et al (2013) SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin Genet 83:257&#x2013;262. https://doi.org/10.1111/j.1399-0004.2012.01896.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2012.01896.x</ArticleId><ArticleId IdType="pubmed">22571692</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiar MA, Yu E, Haj Salem I et al (2021) Evidence for non-Mendelian inheritance in spastic paraplegia 7. Mov Disord 36:1664&#x2013;1675. https://doi.org/10.1002/mds.28528</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28528</ArticleId><ArticleId IdType="pubmed">33598982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger S, Battke F, Sprecher A et al (2016) Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a German ALS cohort. Front Mol Neurosci 9:92. https://doi.org/10.3389/fnmol.2016.00092</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00092</ArticleId><ArticleId IdType="pubmed">27790088</ArticleId><ArticleId IdType="pmc">5061735</ArticleId></ArticleIdList></Reference><Reference><Citation>Garton FC, Benyamin B, Zhao Q et al (2017) Whole exome sequencing and DNA methylation analysis in a clinical amyotrophic lateral sclerosis cohort. Mol Genet genomic Med 5:418&#x2013;428. https://doi.org/10.1002/mgg3.302</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.302</ArticleId><ArticleId IdType="pubmed">28717666</ArticleId><ArticleId IdType="pmc">5511806</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>